Skip to main content
Top
Published in: Critical Care 4/2014

Open Access 01-08-2014 | Research

Mortality of patients infected with HIV in the intensive care unit (2005 through 2010): significant role of chronic hepatitis C and severe sepsis

Authors: José Medrano, Alejando Álvaro-Meca, Alexandre Boyer, María A Jiménez-Sousa, Salvador Resino

Published in: Critical Care | Issue 4/2014

Login to get access

Abstract

Introduction

The combination antiretroviral therapy (cART) has led to decreased opportunistic infections and hospital admissions in human immunodeficiency virus (HIV)-infected patients, but the intensive care unit (ICU) admission rate remains constant (or even increased in some instances) during the cART era. Hepatitis C virus (HCV) infection is associated with an increased risk for hospital admission and/or mortality (particularly those related to severe liver disease) compared with the general population. The aim of this study was to assess the mortality among HIV-infected patients in ICU, and to evaluate the impact of HIV/HCV coinfection and severe sepsis on ICU mortality.

Methods

We carried out a retrospective study based on patients admitted to ICU who were recorded in the Minimum Basic Data Set (2005 through 2010) in Spain. HIV-infected patients (All-HIV-group (n = 1,891)) were divided into two groups: HIV-monoinfected patients (HIV group (n = 1,191)) and HIV/HCV-coinfected patients (HIV/HCV group (n = 700)). A control group (HIV(-)/HCV(-)) was also included (n = 7,496).

Results

All-HIV group had higher frequencies of severe sepsis (57.7% versus 39.4%; P < 0.001) than did the control group. Overall, ICU mortality in patients with severe sepsis was much more frequent than that in patients without severe sepsis (other causes) at days 30 and 90 in HIV-infected patients and the control group (P < 0.001). Moreover, the all-HIV group in the presence or absence of severe sepsis had a higher percentage of death than did the control group at days 7 (P < 0.001), 30 (P < 0.001) and 90 (P < 0.001). Besides, the HIV/HCV group had a higher percentage of death, both in patients with severe sepsis and in patients without severe sepsis compared with the HIV group at days 7 (P < 0.001) and 30 (P < 0.001), whereas no differences were found at day 90. In a bayesian competing-risk model, the HIV/HCV group had a higher mortality risk (adjusted hazard ratio (aHR) = 1.44 (95% CI = 1.30 to 1.59) and aHR = 1.57 (95% CI = 1.38 to 1.78) for patients with and without severe sepsis, respectively).

Conclusions

HIV infection was related to a higher frequency of severe sepsis and death among patients admitted to the ICU. Besides, HIV/HCV coinfection contributed to an increased risk of death in both the presence and the absence of severe sepsis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Global HIV/AIDS response: Epidemic Update and Health Sector Progress Towards Universal Access. Progress Report 2011. 2011, World Health Organization, Geneva, Switzerland Global HIV/AIDS response: Epidemic Update and Health Sector Progress Towards Universal Access. Progress Report 2011. 2011, World Health Organization, Geneva, Switzerland
2.
go back to reference Engsig FN, Hansen ABE, Gerstoft J, Kronborg G, Larsen CS, Obel N: Inpatient admissions and outpatient visits in persons with and without HIV infection in Denmark, 1995-2007. Aids. 2010, 24: 457-461. 10.1097/QAD.0b013e328332828d.CrossRefPubMed Engsig FN, Hansen ABE, Gerstoft J, Kronborg G, Larsen CS, Obel N: Inpatient admissions and outpatient visits in persons with and without HIV infection in Denmark, 1995-2007. Aids. 2010, 24: 457-461. 10.1097/QAD.0b013e328332828d.CrossRefPubMed
3.
go back to reference Crum-Cianflone NF, Grandits G, Echols S, Ganesan A, Landrum M, Weintrob A, Barthel R, Agan B, Program IDCR: Trends and causes of hospitalizations among HIV-infected persons during the late HAART era: what is the impact of CD4 counts and HAART use?. J Acquir Immune Defic Syndr. 2010, 54: 248-257. 10.1097/QAI.0b013e3181c8ef22.PubMedCentralCrossRefPubMed Crum-Cianflone NF, Grandits G, Echols S, Ganesan A, Landrum M, Weintrob A, Barthel R, Agan B, Program IDCR: Trends and causes of hospitalizations among HIV-infected persons during the late HAART era: what is the impact of CD4 counts and HAART use?. J Acquir Immune Defic Syndr. 2010, 54: 248-257. 10.1097/QAI.0b013e3181c8ef22.PubMedCentralCrossRefPubMed
4.
go back to reference Narasimhan M, Posner AJ, DePalo VA, Mayo PH, Rosen MJ: Intensive care in patients with HIV infection in the era of highly active antiretroviral therapy. Chest. 2004, 125: 1800-1804. 10.1378/chest.125.5.1800.CrossRefPubMed Narasimhan M, Posner AJ, DePalo VA, Mayo PH, Rosen MJ: Intensive care in patients with HIV infection in the era of highly active antiretroviral therapy. Chest. 2004, 125: 1800-1804. 10.1378/chest.125.5.1800.CrossRefPubMed
5.
go back to reference Barbier F, Coquet I, Legriel S, Pavie J, Darmon M, Mayaux J, Molina JM, Schlemmer B, Azoulay E: Etiologies and outcome of acute respiratory failure in HIV-infected patients. Intensive Care Med. 2009, 35: 1678-1686. 10.1007/s00134-009-1559-4.CrossRefPubMed Barbier F, Coquet I, Legriel S, Pavie J, Darmon M, Mayaux J, Molina JM, Schlemmer B, Azoulay E: Etiologies and outcome of acute respiratory failure in HIV-infected patients. Intensive Care Med. 2009, 35: 1678-1686. 10.1007/s00134-009-1559-4.CrossRefPubMed
6.
go back to reference Tan DH, Walmsley SL: Management of persons infected with human immunodeficiency virus requiring admission to the intensive care unit. Crit Care Clin. 2013, 29: 603-620. 10.1016/j.ccc.2013.03.010.CrossRefPubMed Tan DH, Walmsley SL: Management of persons infected with human immunodeficiency virus requiring admission to the intensive care unit. Crit Care Clin. 2013, 29: 603-620. 10.1016/j.ccc.2013.03.010.CrossRefPubMed
7.
go back to reference Akgun KM, Gordon K, Pisani M, Fried T, McGinnis KA, Tate JP, Butt AA, Gibert CL, Huang L, Rodriguez-Barradas MC, Rimland D, Justice AC, Crothers K: Risk factors for hospitalization and medical intensive care unit (MICU) admission among HIV-infected Veterans. J Acquir Immune Defic Syndr. 2013, 62: 52-59. 10.1097/QAI.0b013e318278f3fa.PubMedCentralCrossRefPubMed Akgun KM, Gordon K, Pisani M, Fried T, McGinnis KA, Tate JP, Butt AA, Gibert CL, Huang L, Rodriguez-Barradas MC, Rimland D, Justice AC, Crothers K: Risk factors for hospitalization and medical intensive care unit (MICU) admission among HIV-infected Veterans. J Acquir Immune Defic Syndr. 2013, 62: 52-59. 10.1097/QAI.0b013e318278f3fa.PubMedCentralCrossRefPubMed
8.
go back to reference Casalino E, Wolff M, Ravaud P, Choquet C, Bruneel F, Regnier B: Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. Aids. 2004, 18: 1429-1433. 10.1097/01.aids.0000131301.55204.a7.CrossRefPubMed Casalino E, Wolff M, Ravaud P, Choquet C, Bruneel F, Regnier B: Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. Aids. 2004, 18: 1429-1433. 10.1097/01.aids.0000131301.55204.a7.CrossRefPubMed
9.
go back to reference Akgun KM, Huang L, Morris A, Justice AC, Pisani M, Crothers K: Critical illness in HIV-infected patients in the era of combination antiretroviral therapy. Proc Am Thorac Soc. 2011, 8: 301-307. 10.1513/pats.201009-060WR.PubMedCentralCrossRefPubMed Akgun KM, Huang L, Morris A, Justice AC, Pisani M, Crothers K: Critical illness in HIV-infected patients in the era of combination antiretroviral therapy. Proc Am Thorac Soc. 2011, 8: 301-307. 10.1513/pats.201009-060WR.PubMedCentralCrossRefPubMed
10.
go back to reference Akgun KM, Pisani M, Crothers K: The changing epidemiology of HIV-infected patients in the intensive care unit. J Intensive Care Med. 2011, 26: 151-164. 10.1177/0885066610387996.CrossRefPubMed Akgun KM, Pisani M, Crothers K: The changing epidemiology of HIV-infected patients in the intensive care unit. J Intensive Care Med. 2011, 26: 151-164. 10.1177/0885066610387996.CrossRefPubMed
11.
go back to reference Chiang HH, Hung CC, Lee CM, Chen HY, Chen MY, Sheng WH, Hsieh SM, Sun HY, Ho CC, Yu CJ: Admissions to intensive care unit of HIV-infected patients in the era of highly active antiretroviral therapy: etiology and prognostic factors. Crit Care. 2011, 15: R202-10.1186/cc10419.PubMedCentralCrossRefPubMed Chiang HH, Hung CC, Lee CM, Chen HY, Chen MY, Sheng WH, Hsieh SM, Sun HY, Ho CC, Yu CJ: Admissions to intensive care unit of HIV-infected patients in the era of highly active antiretroviral therapy: etiology and prognostic factors. Crit Care. 2011, 15: R202-10.1186/cc10419.PubMedCentralCrossRefPubMed
12.
go back to reference Amancio FF, Lambertucci JR, Cota GF, Antunes CM: Predictors of the short- and long-term survival of HIV-infected patients admitted to a Brazilian intensive care unit. Int J STD AIDS. 2012, 23: 692-697. 10.1258/ijsa.2012.011389.CrossRefPubMed Amancio FF, Lambertucci JR, Cota GF, Antunes CM: Predictors of the short- and long-term survival of HIV-infected patients admitted to a Brazilian intensive care unit. Int J STD AIDS. 2012, 23: 692-697. 10.1258/ijsa.2012.011389.CrossRefPubMed
13.
go back to reference Casalino E, Mendoza-Sassi G, Wolff M, Bedos JP, Gaudebout C, Regnier B, Vachon F: Predictors of short- and long-term survival in HIV-infected patients admitted to the ICU. Chest. 1998, 113: 421-429. 10.1378/chest.113.2.421.CrossRefPubMed Casalino E, Mendoza-Sassi G, Wolff M, Bedos JP, Gaudebout C, Regnier B, Vachon F: Predictors of short- and long-term survival in HIV-infected patients admitted to the ICU. Chest. 1998, 113: 421-429. 10.1378/chest.113.2.421.CrossRefPubMed
14.
go back to reference Vincent B, Timsit JF, Auburtin M, Schortgen F, Bouadma L, Wolff M, Regnier B: Characteristics and outcomes of HIV-infected patients in the ICU: impact of the highly active antiretroviral treatment era. Intensive Care Med. 2004, 30: 859-866. 10.1007/s00134-004-2158-z.CrossRefPubMed Vincent B, Timsit JF, Auburtin M, Schortgen F, Bouadma L, Wolff M, Regnier B: Characteristics and outcomes of HIV-infected patients in the ICU: impact of the highly active antiretroviral treatment era. Intensive Care Med. 2004, 30: 859-866. 10.1007/s00134-004-2158-z.CrossRefPubMed
15.
go back to reference Coquet I, Pavie J, Palmer P, Barbier F, Legriel S, Mayaux J, Molina JM, Schlemmer B, Azoulay E: Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era. Crit Care. 2010, 14: 3-10.1186/cc9056.CrossRef Coquet I, Pavie J, Palmer P, Barbier F, Legriel S, Mayaux J, Molina JM, Schlemmer B, Azoulay E: Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era. Crit Care. 2010, 14: 3-10.1186/cc9056.CrossRef
16.
go back to reference Shepard CW, Finelli L, Alter MJ: Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005, 5: 558-567. 10.1016/S1473-3099(05)70216-4.CrossRefPubMed Shepard CW, Finelli L, Alter MJ: Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005, 5: 558-567. 10.1016/S1473-3099(05)70216-4.CrossRefPubMed
17.
18.
go back to reference McDonald SA, Hutchinson SJ, Mills PR, Bird SM, Cameron S, Dillon JF, Goldberg DJ: The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow’s injecting drug user population. J Viral Hepat. 2011, 18: e126-e133. 10.1111/j.1365-2893.2010.01380.x.CrossRefPubMed McDonald SA, Hutchinson SJ, Mills PR, Bird SM, Cameron S, Dillon JF, Goldberg DJ: The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow’s injecting drug user population. J Viral Hepat. 2011, 18: e126-e133. 10.1111/j.1365-2893.2010.01380.x.CrossRefPubMed
19.
go back to reference Berenguer J, Alejos B, Hernando V, Viciana P, Salavert M, Santos I, Gomez-Sirvent JL, Vidal F, Portilla J, Del Amo J: Trends in mortality according to hepatitis C virus serostatus in the era of combination antiretroviral therapy. Aids. 2012, 26: 2241-2246. 10.1097/QAD.0b013e3283574e94.CrossRefPubMed Berenguer J, Alejos B, Hernando V, Viciana P, Salavert M, Santos I, Gomez-Sirvent JL, Vidal F, Portilla J, Del Amo J: Trends in mortality according to hepatitis C virus serostatus in the era of combination antiretroviral therapy. Aids. 2012, 26: 2241-2246. 10.1097/QAD.0b013e3283574e94.CrossRefPubMed
20.
go back to reference Gonzalez-Garcia JJ, Mahillo B, Hernandez S, Pacheco R, Diz S, Garcia P, Esteban H, Arribas JR, Quereda C, Rubio R, Díez J, Moreno S, Vázquez-Rodríguez JJ: Prevalences of hepatitis virus coinfection and indications for chronic hepatitis C virus treatment and liver transplantation in Spanish HIV-infected patients: The GESIDA 29/02 and FIPSE 12185/01 Multicenter Study. Enferm Infecc Microbiol Clin. 2005, 23: 340-348. 10.1157/13076173.CrossRefPubMed Gonzalez-Garcia JJ, Mahillo B, Hernandez S, Pacheco R, Diz S, Garcia P, Esteban H, Arribas JR, Quereda C, Rubio R, Díez J, Moreno S, Vázquez-Rodríguez JJ: Prevalences of hepatitis virus coinfection and indications for chronic hepatitis C virus treatment and liver transplantation in Spanish HIV-infected patients: The GESIDA 29/02 and FIPSE 12185/01 Multicenter Study. Enferm Infecc Microbiol Clin. 2005, 23: 340-348. 10.1157/13076173.CrossRefPubMed
22.
go back to reference Lopez-Dieguez M, Montes ML, Pascual-Pareja JF, Quereda C, Von Wichmann MA, Berenguer J, Tural C, Hernando A, Gonzalez-Garcia J, Serrano L, Arribas JR: The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patients. Aids. 2011, 25: 899-904. 10.1097/QAD.0b013e3283454174.CrossRefPubMed Lopez-Dieguez M, Montes ML, Pascual-Pareja JF, Quereda C, Von Wichmann MA, Berenguer J, Tural C, Hernando A, Gonzalez-Garcia J, Serrano L, Arribas JR: The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patients. Aids. 2011, 25: 899-904. 10.1097/QAD.0b013e3283454174.CrossRefPubMed
23.
go back to reference Soriano V, Vispo E, Fernandez-Montero JV, Labarga P, Barreiro P: Update on HIV/HCV coinfection. Curr HIV/AIDS Rep. 2013, 10: 226-234. 10.1007/s11904-013-0169-5.CrossRefPubMed Soriano V, Vispo E, Fernandez-Montero JV, Labarga P, Barreiro P: Update on HIV/HCV coinfection. Curr HIV/AIDS Rep. 2013, 10: 226-234. 10.1007/s11904-013-0169-5.CrossRefPubMed
24.
go back to reference Bruce N, Pope D, Stanistreet D: Case-control studies. Quantitative Methods for Health Research: A Practical Interactive Guide to Epidemiology and Statistics. 2008, John Wiley & Sons, Ltd, London, 257-305. 10.1002/9780470725337.ch6.CrossRef Bruce N, Pope D, Stanistreet D: Case-control studies. Quantitative Methods for Health Research: A Practical Interactive Guide to Epidemiology and Statistics. 2008, John Wiley & Sons, Ltd, London, 257-305. 10.1002/9780470725337.ch6.CrossRef
25.
go back to reference Ury HK: Efficiency of case-control studies with multiple controls per case: continuous or dichotomous data. Biometrics. 1975, 31: 643-649. 10.2307/2529548.CrossRefPubMed Ury HK: Efficiency of case-control studies with multiple controls per case: continuous or dichotomous data. Biometrics. 1975, 31: 643-649. 10.2307/2529548.CrossRefPubMed
26.
go back to reference Taylor JM: Choosing the number of controls in a matched case-control study: some sample size, power and efficiency considerations. Stat Med. 1986, 5: 29-36. 10.1002/sim.4780050106.CrossRefPubMed Taylor JM: Choosing the number of controls in a matched case-control study: some sample size, power and efficiency considerations. Stat Med. 1986, 5: 29-36. 10.1002/sim.4780050106.CrossRefPubMed
27.
go back to reference Gail MH: Frequency matching. Encyclopedia of Biostatistics. Edited by: Armitage P, Colton T. 2005, John Wiley & Sons, Ltd, Hoboken, NJ, 2 Gail MH: Frequency matching. Encyclopedia of Biostatistics. Edited by: Armitage P, Colton T. 2005, John Wiley & Sons, Ltd, Hoboken, NJ, 2
28.
go back to reference Instituto Nacional de Salud. Ministerio de Sanidad y Consumo. 2001 Instituto Nacional de Salud. Ministerio de Sanidad y Consumo. 2001
29.
go back to reference The Web's Free 2014 Medical Coding Reference. 2010 ICD-9-CM Diagnosis Codes. The Web's Free 2014 Medical Coding Reference. 2010 ICD-9-CM Diagnosis Codes.
30.
go back to reference Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001, 29: 1303-1310. 10.1097/00003246-200107000-00002.CrossRefPubMed Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001, 29: 1303-1310. 10.1097/00003246-200107000-00002.CrossRefPubMed
31.
go back to reference Kneib T, Hennerfeind A: Bayesian semi parametric multi-state models. Stat Model. 2008, 8: 169-198. 10.1177/1471082X0800800203.CrossRef Kneib T, Hennerfeind A: Bayesian semi parametric multi-state models. Stat Model. 2008, 8: 169-198. 10.1177/1471082X0800800203.CrossRef
32.
go back to reference Gelfand AE, Smith AFM: Sampling-based approaches to calculating marginal densities. J Am Stat Assoc. 1990, 85: 398-409. 10.1080/01621459.1990.10476213.CrossRef Gelfand AE, Smith AFM: Sampling-based approaches to calculating marginal densities. J Am Stat Assoc. 1990, 85: 398-409. 10.1080/01621459.1990.10476213.CrossRef
33.
go back to reference Andersen PK, Geskus RB, de Witte T, Putter H: Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol. 2012, 41: 861-870. 10.1093/ije/dyr213.PubMedCentralCrossRefPubMed Andersen PK, Geskus RB, de Witte T, Putter H: Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol. 2012, 41: 861-870. 10.1093/ije/dyr213.PubMedCentralCrossRefPubMed
35.
go back to reference Bayesian Inference in Structured Additive Regression Models. Version 2.1. Bayesian Inference in Structured Additive Regression Models. Version 2.1.
36.
go back to reference Davaro RE, Thirumalai A: Life-threatening complications of HIV infection. J Intensive Care Med. 2007, 22: 73-81. 10.1177/0885066606297964.CrossRefPubMed Davaro RE, Thirumalai A: Life-threatening complications of HIV infection. J Intensive Care Med. 2007, 22: 73-81. 10.1177/0885066606297964.CrossRefPubMed
37.
go back to reference Croda J, Croda MG, Neves A, de Sousa dos Santos S: Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit. Crit Care Med. 2009, 37: 1605-1611. 10.1097/CCM.0b013e31819da8c7.PubMedCentralCrossRefPubMed Croda J, Croda MG, Neves A, de Sousa dos Santos S: Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit. Crit Care Med. 2009, 37: 1605-1611. 10.1097/CCM.0b013e31819da8c7.PubMedCentralCrossRefPubMed
38.
go back to reference Huang L, Quartin A, Jones D, Havlir DV: Intensive care of patients with HIV infection. N Engl J Med. 2006, 355: 173-181. 10.1056/NEJMra050836.CrossRefPubMed Huang L, Quartin A, Jones D, Havlir DV: Intensive care of patients with HIV infection. N Engl J Med. 2006, 355: 173-181. 10.1056/NEJMra050836.CrossRefPubMed
39.
go back to reference Morris A, Creasman J, Turner J, Luce JM, Wachter RM, Huang L: Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy. Am J Respir Crit Care Med. 2002, 166: 262-267. 10.1164/rccm.2111025.CrossRefPubMed Morris A, Creasman J, Turner J, Luce JM, Wachter RM, Huang L: Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy. Am J Respir Crit Care Med. 2002, 166: 262-267. 10.1164/rccm.2111025.CrossRefPubMed
40.
go back to reference Akgun KM, Tate JP, Pisani M, Fried T, Butt AA, Gibert CL, Huang L, Rodriguez-Barradas MC, Rimland D, Justice AC, Crothers K: Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era. Crit Care Med. 2013, 41: 1458-1467. 10.1097/CCM.0b013e31827caa46.PubMedCentralCrossRefPubMed Akgun KM, Tate JP, Pisani M, Fried T, Butt AA, Gibert CL, Huang L, Rodriguez-Barradas MC, Rimland D, Justice AC, Crothers K: Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era. Crit Care Med. 2013, 41: 1458-1467. 10.1097/CCM.0b013e31827caa46.PubMedCentralCrossRefPubMed
41.
go back to reference Silva JM, dos Santos SS: Sepsis in AIDS patients: clinical, etiological and inflammatory characteristics. J Int AIDS Soc. 2013, 16: 17344-10.7448/IAS.16.1.17344.PubMedCentralCrossRefPubMed Silva JM, dos Santos SS: Sepsis in AIDS patients: clinical, etiological and inflammatory characteristics. J Int AIDS Soc. 2013, 16: 17344-10.7448/IAS.16.1.17344.PubMedCentralCrossRefPubMed
42.
go back to reference Macias J, Berenguer J, Japon MA, Giron JA, Rivero A, Lopez-Cortes LF, Moreno A, Gonzalez-Serrano M, Iribarren JA, Ortega E, Miralles P, Mira JA, Pineda JA: Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus. Hepatology. 2009, 50: 1056-1063. 10.1002/hep.23136.CrossRefPubMed Macias J, Berenguer J, Japon MA, Giron JA, Rivero A, Lopez-Cortes LF, Moreno A, Gonzalez-Serrano M, Iribarren JA, Ortega E, Miralles P, Mira JA, Pineda JA: Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus. Hepatology. 2009, 50: 1056-1063. 10.1002/hep.23136.CrossRefPubMed
43.
go back to reference Lo Re V, Kostman JR, Amorosa VK: Management complexities of HIV/hepatitis C virus coinfection in the twenty-first century. Clin Liver Dis. 2008, 12: 587-609. 10.1016/j.cld.2008.03.009.PubMedCentralCrossRefPubMed Lo Re V, Kostman JR, Amorosa VK: Management complexities of HIV/hepatitis C virus coinfection in the twenty-first century. Clin Liver Dis. 2008, 12: 587-609. 10.1016/j.cld.2008.03.009.PubMedCentralCrossRefPubMed
44.
go back to reference Gustot T, Durand F, Lebrec D, Vincent JL, Moreau R: Severe sepsis in cirrhosis. Hepatology. 2009, 50: 2022-2033. 10.1002/hep.23264.CrossRefPubMed Gustot T, Durand F, Lebrec D, Vincent JL, Moreau R: Severe sepsis in cirrhosis. Hepatology. 2009, 50: 2022-2033. 10.1002/hep.23264.CrossRefPubMed
45.
go back to reference Laleman W, Verbeke L, Meersseman P, Wauters J, van Pelt J, Cassiman D, Wilmer A, Verslype C, Nevens F: Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions. Expert Rev Gastroenterol Hepatol. 2011, 5: 523-537. 10.1586/egh.11.47.CrossRefPubMed Laleman W, Verbeke L, Meersseman P, Wauters J, van Pelt J, Cassiman D, Wilmer A, Verslype C, Nevens F: Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions. Expert Rev Gastroenterol Hepatol. 2011, 5: 523-537. 10.1586/egh.11.47.CrossRefPubMed
46.
go back to reference Moreau R, Hadengue A, Soupison T, Kirstetter P, Mamzer MF, Vanjak D, Vauquelin P, Assous M, Sicot C: Septic shock in patients with cirrhosis: hemodynamic and metabolic characteristics and intensive care unit outcome. Crit Care Med. 1992, 20: 746-750. 10.1097/00003246-199206000-00008.CrossRefPubMed Moreau R, Hadengue A, Soupison T, Kirstetter P, Mamzer MF, Vanjak D, Vauquelin P, Assous M, Sicot C: Septic shock in patients with cirrhosis: hemodynamic and metabolic characteristics and intensive care unit outcome. Crit Care Med. 1992, 20: 746-750. 10.1097/00003246-199206000-00008.CrossRefPubMed
47.
go back to reference Japiassu AM, Amancio RT, Mesquita EC, Medeiros DM, Bernal HB, Nunes EP, Luz PM, Grinsztejn B, Bozza FA: Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients. Crit Care. 2010, 14: R152-10.1186/cc9221.PubMedCentralCrossRefPubMed Japiassu AM, Amancio RT, Mesquita EC, Medeiros DM, Bernal HB, Nunes EP, Luz PM, Grinsztejn B, Bozza FA: Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients. Crit Care. 2010, 14: R152-10.1186/cc9221.PubMedCentralCrossRefPubMed
48.
go back to reference Greenberg JA, Lennox JL, Martin GS: Outcomes for critically ill patients with HIV and severe sepsis in the era of highly active antiretroviral therapy. J Crit Care. 2012, 27: 51-57. 10.1016/j.jcrc.2011.08.015.PubMedCentralCrossRefPubMed Greenberg JA, Lennox JL, Martin GS: Outcomes for critically ill patients with HIV and severe sepsis in the era of highly active antiretroviral therapy. J Crit Care. 2012, 27: 51-57. 10.1016/j.jcrc.2011.08.015.PubMedCentralCrossRefPubMed
49.
go back to reference Powell K, Davis JL, Morris AM, Chi A, Bensley MR, Huang L: Survival for patients with HIV admitted to the ICU continues to improve in the current era of combination antiretroviral therapy. Chest. 2009, 135: 11-17. 10.1378/chest.08-0980.PubMedCentralCrossRefPubMed Powell K, Davis JL, Morris AM, Chi A, Bensley MR, Huang L: Survival for patients with HIV admitted to the ICU continues to improve in the current era of combination antiretroviral therapy. Chest. 2009, 135: 11-17. 10.1378/chest.08-0980.PubMedCentralCrossRefPubMed
50.
go back to reference Nickas G, Wachter RM: Outcomes of intensive care for patients with human immunodeficiency virus infection. Arch Intern Med. 2000, 160: 541-547. 10.1001/archinte.160.4.541.CrossRefPubMed Nickas G, Wachter RM: Outcomes of intensive care for patients with human immunodeficiency virus infection. Arch Intern Med. 2000, 160: 541-547. 10.1001/archinte.160.4.541.CrossRefPubMed
51.
go back to reference Afessa B, Green B: Clinical course, prognostic factors, and outcome prediction for HIV patients in the ICU: The PIP (pulmonary complications, ICU support, and prognostic factors in hospitalized patients with HIV) study. Chest. 2000, 118: 138-145. 10.1378/chest.118.1.138.CrossRefPubMed Afessa B, Green B: Clinical course, prognostic factors, and outcome prediction for HIV patients in the ICU: The PIP (pulmonary complications, ICU support, and prognostic factors in hospitalized patients with HIV) study. Chest. 2000, 118: 138-145. 10.1378/chest.118.1.138.CrossRefPubMed
52.
go back to reference Alves C, Nicolas JM, Miro JM, Torres A, Agusti C, Gonzalez J, Rano A, Benito N, Moreno A, Garcia F, Millá J, Gatell JM: Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients. Eur Respir J. 2001, 17: 87-93. 10.1183/09031936.01.17100870.CrossRefPubMed Alves C, Nicolas JM, Miro JM, Torres A, Agusti C, Gonzalez J, Rano A, Benito N, Moreno A, Garcia F, Millá J, Gatell JM: Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients. Eur Respir J. 2001, 17: 87-93. 10.1183/09031936.01.17100870.CrossRefPubMed
53.
go back to reference Vargas-Infante YA, Guerrero ML, Ruiz-Palacios GM, Soto-Ramirez LE, Del Rio C, Carranza J, Dominguez-Cherit G, Sierra-Madero JG: Improving outcome of human immunodeficiency virus-infected patients in a Mexican intensive care unit. Arch Med Res. 2007, 38: 827-833. 10.1016/j.arcmed.2007.05.007.CrossRefPubMed Vargas-Infante YA, Guerrero ML, Ruiz-Palacios GM, Soto-Ramirez LE, Del Rio C, Carranza J, Dominguez-Cherit G, Sierra-Madero JG: Improving outcome of human immunodeficiency virus-infected patients in a Mexican intensive care unit. Arch Med Res. 2007, 38: 827-833. 10.1016/j.arcmed.2007.05.007.CrossRefPubMed
54.
go back to reference Morris A, Wachter RM, Luce J, Turner J, Huang L: Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia. Aids. 2003, 17: 73-80. 10.1097/00002030-200301030-00010.CrossRefPubMed Morris A, Wachter RM, Luce J, Turner J, Huang L: Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia. Aids. 2003, 17: 73-80. 10.1097/00002030-200301030-00010.CrossRefPubMed
55.
go back to reference Miller RF, Allen E, Copas A, Singer M, Edwards SG: Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy. Thorax. 2006, 61: 716-721. 10.1136/thx.2005.055905.PubMedCentralCrossRefPubMed Miller RF, Allen E, Copas A, Singer M, Edwards SG: Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy. Thorax. 2006, 61: 716-721. 10.1136/thx.2005.055905.PubMedCentralCrossRefPubMed
56.
go back to reference Dickson SJ, Batson S, Copas AJ, Edwards SG, Singer M, Miller RF: Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy. Thorax. 2007, 62: 964-968. 10.1136/thx.2006.072256.PubMedCentralCrossRefPubMed Dickson SJ, Batson S, Copas AJ, Edwards SG, Singer M, Miller RF: Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy. Thorax. 2007, 62: 964-968. 10.1136/thx.2006.072256.PubMedCentralCrossRefPubMed
57.
go back to reference Khouli H, Afrasiabi A, Shibli M, Hajal R, Barrett CR, Homel P: Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. J Intensive Care Med. 2005, 20: 327-333. 10.1177/0885066605281087.CrossRefPubMed Khouli H, Afrasiabi A, Shibli M, Hajal R, Barrett CR, Homel P: Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. J Intensive Care Med. 2005, 20: 327-333. 10.1177/0885066605281087.CrossRefPubMed
58.
go back to reference van Lelyveld SF, Wind CM, Mudrikova T, van Leeuwen HJ, de Lange DW, Hoepelman AI: Short- and long-term outcome of HIV-infected patients admitted to the intensive care unit. Eur J Clin Microbiol Infect Dis. 2011, 30: 1085-1093. 10.1007/s10096-011-1196-z.CrossRefPubMed van Lelyveld SF, Wind CM, Mudrikova T, van Leeuwen HJ, de Lange DW, Hoepelman AI: Short- and long-term outcome of HIV-infected patients admitted to the intensive care unit. Eur J Clin Microbiol Infect Dis. 2011, 30: 1085-1093. 10.1007/s10096-011-1196-z.CrossRefPubMed
59.
go back to reference Morquin D, Le Moing V, Mura T, Makinson A, Klouche K, Jonquet O, Reynes J, Corne P: Short- and long-term outcomes of HIV-infected patients admitted to the intensive care unit: impact of antiretroviral therapy and immunovirological status. Ann Intensive Care. 2012, 2: 25-10.1186/2110-5820-2-25.PubMedCentralCrossRefPubMed Morquin D, Le Moing V, Mura T, Makinson A, Klouche K, Jonquet O, Reynes J, Corne P: Short- and long-term outcomes of HIV-infected patients admitted to the intensive care unit: impact of antiretroviral therapy and immunovirological status. Ann Intensive Care. 2012, 2: 25-10.1186/2110-5820-2-25.PubMedCentralCrossRefPubMed
60.
go back to reference Ho AM, Dion PW, Ng CS, Karmakar MK: Understanding immortal time bias in observational cohort studies. Anaesthesia. 2013, 68: 126-130. 10.1111/anae.12120.CrossRefPubMed Ho AM, Dion PW, Ng CS, Karmakar MK: Understanding immortal time bias in observational cohort studies. Anaesthesia. 2013, 68: 126-130. 10.1111/anae.12120.CrossRefPubMed
61.
go back to reference Levesque LE, Hanley JA, Kezouh A, Suissa S: Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ. 2010, 340: b5087-10.1136/bmj.b5087.CrossRefPubMed Levesque LE, Hanley JA, Kezouh A, Suissa S: Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ. 2010, 340: b5087-10.1136/bmj.b5087.CrossRefPubMed
62.
go back to reference Shen HN, Lu CL, Yang HH: Epidemiologic trend of severe sepsis in Taiwan from 1997 through 2006. Chest. 2010, 138: 298-304. 10.1378/chest.09-2205.CrossRefPubMed Shen HN, Lu CL, Yang HH: Epidemiologic trend of severe sepsis in Taiwan from 1997 through 2006. Chest. 2010, 138: 298-304. 10.1378/chest.09-2205.CrossRefPubMed
63.
go back to reference Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003, 348: 1546-1554. 10.1056/NEJMoa022139.CrossRefPubMed Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003, 348: 1546-1554. 10.1056/NEJMoa022139.CrossRefPubMed
Metadata
Title
Mortality of patients infected with HIV in the intensive care unit (2005 through 2010): significant role of chronic hepatitis C and severe sepsis
Authors
José Medrano
Alejando Álvaro-Meca
Alexandre Boyer
María A Jiménez-Sousa
Salvador Resino
Publication date
01-08-2014
Publisher
BioMed Central
Published in
Critical Care / Issue 4/2014
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-014-0475-3

Other articles of this Issue 4/2014

Critical Care 4/2014 Go to the issue